A carregar...
Eribulin mesylate in the treatment of metastatic breast cancer
The treatment of metastatic breast cancer (MBC) has become increasingly challenging as the primary goals of therapy include prolonging life without added toxicity. While multiple agents are approved for the therapy of MBC, there is no standard approach for therapy beyond the second-line. Eribulin me...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3266863/ https://ncbi.nlm.nih.gov/pubmed/22291464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S19811 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|